相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)
Hepatic fibrosis changes in patients with chronic hepatitis C infection who respond to direct-acting antivirals
Khalid Alswat et al.
ANNALS OF SAUDI MEDICINE (2022)
Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir
Mahmoud Abdo et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Direct-acting antiviral therapy of chronic hepatitis C improves liver fibrosis, assessed by histological examination and laboratory markers
Chun-Han Cheng et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)
Antiviral treatment for hepatitis C is associated with a reduced risk of atherosclerotic cardiovascular outcomes: A systematic review and meta-analysis
Xin Su et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment
Domenico Iossa et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy
Cesare Mazzaro et al.
VIRUSES-BASEL (2021)
Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update
Hrvoje Roguljic et al.
FRONTIERS IN PHARMACOLOGY (2021)
Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective
Mohammad Said Ramadan et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy
Rui Huang et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
Effects of Eradication of HCV on Cardiovascular Risk and Preclinical Atherosclerosis in HIV/HCV-Coinfected Patients
Ana Carrero et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2020)
Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication
Chung-Feng Huang et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2020)
Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis
Christiana Graf et al.
JOURNAL OF CLINICAL MEDICINE (2020)
EASL recommendations on treatment of hepatitis C: Final update of the series
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2020)
Assessing liver fibrosis without biopsy in patients with HCV or NAFLD
Tavankit Singh et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2019)
Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study
Kuan Ken Lee et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology
Donald M. Lloyd-Jones et al.
CIRCULATION (2019)
Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events
Adeel A. Butt et al.
GASTROENTEROLOGY (2019)
The Unraveled Link Between Antiviral Therapy and Heart Failure Hospitalization in Chronic Hepatitis C Virus Infection - A Nationwide Cohort Study -
Ming-Shyan Lin et al.
CIRCULATION JOURNAL (2018)
Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication - comparison of the new direct-acting antiviral agents with the old regimens
Joana Rita Carvalho et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis
Naoki Kawagishi et al.
PLOS ONE (2018)
Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
Luigi Elio Adinolfi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon et al.
GASTROENTEROLOGY (2017)
Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon
Aisha Elsharkawy et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons
K. W. Chew et al.
JOURNAL OF VIRAL HEPATITIS (2017)
The future of liver transplantation for viral hepatitis
Francois Durand et al.
LIVER INTERNATIONAL (2017)
Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review
Ahmed Babiker et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2017)
Treatment of Extrahepatic Manifestations of Hepatitis C Virus
Elisabetta Degasperi et al.
CLINICS IN LIVER DISEASE (2017)
Rationale for the use of statins in liver disease
Robert Schierwagen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
Interaction of Gender and Hepatitis C in Risk of Chronic Renal Failure After Liver Transplantation
Stephen Lp et al.
ANNALS OF HEPATOLOGY (2017)
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies
Salvatore Petta et al.
GASTROENTEROLOGY (2016)
Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons
Kara W. Chew et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2015)
Effect of Sofosbuvir and Ribavirin Treatment on Peripheral and Hepatic Lipid Metabolism in Chronic Hepatitis C Virus, Genotype 1-Infected Patients
Eric G. Meissner et al.
HEPATOLOGY (2015)
EASL Recommendations on Treatment of Hepatitis C 2015
JOURNAL OF HEPATOLOGY (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
G. R. Foster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
J. J. Feld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment
Brian P. Lam et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2015)
Thromboembolic Events Among Patients with Hepatitis C Virus Infection and Cirrhosis: A Matched-Cohort Study
Cheryl Enger et al.
ADVANCES IN THERAPY (2014)
Impact of Hepatitis C Seropositivity on the Risk of Coronary Heart Disease Events
Naga Venkata Krishna Chand Pothineni et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
David C. Goff et al.
CIRCULATION (2014)
Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
Enrica Golia et al.
CURRENT ATHEROSCLEROSIS REPORTS (2014)
Extrahepatic manifestations of chronic hepatitis C virus infection
Patrice Cacoub et al.
DIGESTIVE AND LIVER DISEASE (2014)
The Effects of Female Sex, Viral Genotype, and IL28B Genotype on Spontaneous Clearance of Acute Hepatitis C Virus Infection
Jason Grebely et al.
HEPATOLOGY (2014)
Antiviral Treatment for Hepatitis C Virus Infection Is Associated With Improved Renal and Cardiovascular Outcomes in Diabetic Patients
Yao-Chun Hsu et al.
HEPATOLOGY (2014)
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms
Luigi E. Adinolfi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Chronic HCV infection is a risk factor of ischemic stroke
Luigi E. Adinolfi et al.
ATHEROSCLEROSIS (2013)
Effects of Hepatitis C virus on cardiovascular risk in infected patients: A comparative study
C. P. M. S. Oliveira et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population
L. Kakinami et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2013)
Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study
Mei-Hsuan Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Hepatitis C virus RNA localization in human carotid plaques
Maria Boddi et al.
JOURNAL OF CLINICAL VIROLOGY (2010)
Hepatitis C Virus Infection and the Risk of Coronary Disease
Adeel A. Butt et al.
CLINICAL INFECTIOUS DISEASES (2009)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
Hepatitis C Infection is Associated With Increased Coronary Artery Atherosclerosis Defined by Modified Reardon Severity Score System
Omer Alyan et al.
CIRCULATION JOURNAL (2008)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Hepatitis C virus (HCV) infection:: A systemic disease
Antonio Craxi et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)
分享论文
